We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£148.31
Springer - Drug Resistance in Leukemia and Lymphoma III
Price data last checked 62 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£148 today · previous high £148 · all-time low £148
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 29 days · 29 data points (no recent data)
Price Distribution
Price distribution over 29 days • 1 price levels
Price Analysis
Most common price: £148 (29 days, 100.0%)
Price range: £148 - £148
Price levels: 1 different prices over 29 days
Description
Key Features
Contains the full proceedings from the third International Symposium on Drug Resistance in Leukemia and Lymphoma held in Amsterdam.
Part of the recognized Advances in Experimental Medicine and Biology series, volume 457.
Addresses the gap between laboratory research and clinical practice for oncology professionals.
Provides a deep look into the challenges of cellular drug resistance in leukemia and lymphoma treatments.
Offers essential research data for clinicians and scientists focused on hematologic diseases.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1461371805
- Domain
- Amazon UK
- Publication Date
- 05 November 2012
- Listed Since
- 03 March 2013
Barcode
No barcode data available
Similar Products You Might Like
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
Springer
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
CRC Press
Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1
Springer
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
Springer
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)
Elsevier
Academic Press - Treatment of Leukemia and Lymphoma Vol 51
Academic Press
Chemotherapy for Leukemia: Novel Drugs and Treatment
Springer
Frontiers in Leukemia Pharmacotherapy
Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
Springer
Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
Springer
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
Springer
Cancer Cell Chemoresistance And Chemosensitization
Scientific Publishing
Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)
Humana
Drug Resistance in Cancer Cells
Springer
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
Springer
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
Humana
Experimental Leukemia: History, Biology and Genetics Book
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Springer
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
Springer
Springer - New Agents for the Treatment of Acute Lymphoblastic Leukemia
Springer
Leukemias
Springer